ANSM completes inspection at Lupin’s Mandideep facility

06 Aug 2019 Evaluate

The French National Agency for Medicines and Health Products Safety (ANSM) has completed the Good Manufacturing Practices (GMP) inspection at Lupin’s finished product manufacturing facility (Unit-1) at Mandideep. The inspection was conducted between April 8, 2019 and April 12, 2019. The ANSM inspection closed with no critical or major observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2138.65 -12.40 (-0.58%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×